New Zealand markets open in 5 hours 4 minutes

PerkinElmer, Inc. (PKI)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
175.34-3.13 (-1.75%)
As of 10:56AM EST. Market open.
Full screen
Trade prices are not sourced from all markets
Previous close178.47
Open175.18
Bid174.88 x 900
Ask175.16 x 1100
Day's range173.88 - 177.27
52-week range119.95 - 203.16
Volume169,459
Avg. volume989,850
Market cap22.128B
Beta (5Y monthly)1.08
PE ratio (TTM)17.49
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yield0.28 (0.16%)
Ex-dividend date20 Jan 2022
1y target estN/A
All
News
  • Business Wire

    PerkinElmer Updates Fourth Quarter Outlook; To Hold Earnings Call on Tuesday, February 1, 2022

    WALTHAM, Mass., January 11, 2022--PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, today announced that it anticipates reported and organic revenue growth for the fourth quarter of 2021 of approximately -1% and -12%, respectively, versus the same period a year ago. Adjusted earnings per share from continuing operations is expected to be at least $2.40 for the fourth quarter ended January 2, 2022.

  • Business Wire

    PerkinElmer to Present Virtually at J.P. Morgan Healthcare Conference

    WALTHAM, Mass., December 21, 2021--PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, today announced that the Company will present virtually at the annual J.P. Morgan Healthcare Conference on Tuesday, January 11, 2022 at 11:15 a.m. ET.

  • Business Wire

    PerkinElmer Launches NEXTFLEX Variant-Seq SARS-CoV-2 Kit v2 to Strengthen SARS-CoV-2 Surveillance

    WALTHAM, Mass., December 08, 2021--PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, today announced the research use only (RUO) launch of the NEXTFLEX® Variant-Seq™ SARS-CoV-2 Kit v2 to accelerate the detection of SARS-CoV-2 variants. This complete next generation sequencing (NGS) solution will allow laboratories to increase sequencing throughput and make reliable variant identifications.